Fully automated sequential immunofluorescence (seqIF) for hyperplex spatial proteomics

François Rivest1, Deniz Eroglu1, Benjamin Pelz1

  • 1Lunaphore Technologies SA, Tolochenaz, Switzerland.

Scientific Reports
|October 9, 2023
PubMed

Insights

A new method called sequential ImmunoFluorescence (seqIF) allows for multiplexed protein detection in tissues, preserving spatial context for tumor microenvironment research. This automated technique provides high-plex data quickly using standard antibodies, aiding immune-oncology studies.

Area of Science:

  • Proteomics
  • Biomarker Discovery
  • Spatial Biology

Background:

  • Tissues are complex, with cell-cell and cell-matrix interactions crucial for function.
  • Investigating the tumor microenvironment requires preserving spatial context in proteomic analysis.
  • Existing methods may struggle with high-plex spatial protein detection.

Purpose of the Study:

  • To introduce and characterize a novel multiplexed protein biomarker detection method, sequential ImmunoFluorescence (seqIF).
  • To demonstrate the utility of seqIF for spatial proteomics in complex tissue samples.
  • To enable advanced spatial analysis for immune-oncology and clinical applications.

Main Methods:

  • Sequential ImmunoFluorescence (seqIF) on the COMET instrument.
  • Automated antibody incubation and elution cycles with in-situ imaging.
  • Utilized an integrated microscope and microfluidic chip for optimized sample access.

Main Results:

  • Achieved 40-plex protein detection on single tissue sections in under 24 hours.
  • Demonstrated high data quality, including elution efficiency, epitope stability, and reproducibility.
  • Successfully applied seqIF to both tumor and healthy tissue samples.

Conclusions:

  • seqIF is a streamlined, automated method for high-plex spatial proteomics using off-the-shelf antibodies.
  • The method provides high-quality data suitable for downstream analysis in immune-oncology.
  • seqIF facilitates spatial analysis and shows potential for clinical adoption.